Krabb.is
Elmer
ress
J Endocrinol Metab. 2014;4(5-6):153-154
Ectopic Cushing Syndrome Due to Colon Cancer With Dual
Bryndis Baldvinsdottira, Jon G. Jonassonb, c, Uggi P. Agnarssonc, d, Helga A. Sigurjonsdottirc, e, f
ology ward at Landspitali University Hospital in Reykjavik,
Iceland (LSH) with NSTEMI, hypertension and heart failure
We report a case of colon cancer, and the most interesting presenta-
following a 7-day stay at a primary hospital (HSU). She had
tion was Cushing's syndrome (CS). A 72-year-old woman was diag-
been admitted to HSU with increased fatigue, ankle edema
nosed with CS when admitted to hospital because of NSTEMI and
and resistant hypertension. There she was found to be hyper-
heart failure. The patient succumbed to her illness only 4 weeks after
glycemic, hypokalemic and hypertensive. Medical treatment
presentation. The colon cancer was a combined adenocarcinoma and
was without success. At arrival to LSH she had hypertension
small cell carcinoma, solely the latter component responsible for pro-
(169/66 mm Hg), hyperglycemia (serum glucose level 23.6
ducing adrenocorticotropin hormone (ACTH).
mmol/L) and profound hypokalemia (serum potassium levels
2.0 mmol/L), despite ongoing potassium-sparing anti-hyper-
Keywords: Colon cancer; Cushing's syndrome; Ectopic Cushing's
tensive treatment (enalapril 10 mg daily, losartan 50 mg daily
syndrome; ACTH; Small cell cancer; Adenocarcinoma; Hyperten-
and spironalactone 50 mg daily).
sion; Hypokalemia
She had cushingoid appearance with central obesity,
moon-face and thinning of the skin, but not stria or hirsutism.
The patient had been treated for hypertension for several years
with no history of hypokalemia. Serum levels of potassium 2
months earlier were normal. She complained of muscle weak-
Ectopic secretion of adrenocorticotropin hormone (ACTH) is
ness. Serum cortisol level, measured at 16:30 pm was 2,613
a rare cause of Cushing's syndrome (CS), and when diagnosed
nmol/L (reference: 170 - 700 nmol/L).
the primary tumor is most often lung cancer. Colon cancer as a
Morning serum cortisol levels and plasma ACTH were
cause is extremely rare in spite of being among the most com-
3,113 nmol/L (reference: 170 - 700 nmol/L) and 769 ng/L (ref-
mon malignancies in the general population.
erence: 0 - 46 ng/L), respectively. After low-dose overnight,
To our knowledge, there are only 10 [1-3] reported cases
dexamethason suppression test (DST), with 1 mg dexametha-
of ACTH-secreting colon cancer cases in the literature.
sone given orally at 23:00 pm, serum cortisol level at 8:00 am
was not suppressed, 3,416 nmol/L. A 2-day low dose DST (0.5
Case Report
mg every 6 h for 48 h) was performed without suppression of
morning serum levels of cortisol that were 4,675 nmol/L at the
start of the test, 4,679 nmol/L after 24 h DST and 4,919 nmol/L
A 72-year-old Caucasian woman was admitted to the cardi-
after 48 h suppression. Plasma ACTH level was 4,658 ng/L
(reference: 0 - 46 ng/L) 24 h after the 2-day DST.
Computed tomography (CT) of the abdomen showed a
Manuscript accepted for publication December 15, 2014
solid tumor of uncertain etiology at the recto-sigmoid junction
and widespread metastases in the liver and lymph nodes.
aDepartment of Medicine, Landspitali University Hospital, Reykjavik, Iceland
A CT of the thorax showed metastases in the lungs, and
Department of Pathology, Landspitali University Hospital, Reykjavik, Ice-
magnetic resonance imaging (MRI) of the pituitary gland was
cFaculty of Medicine, University of Iceland, Reykjavik, Iceland
dDepartment of Cardiology, Landspitali University Hospital, Reykjavik, Ice-
The 24 h urine sample for 5-HIAA, adrenalin, noradrena-
lin, dopamin, VMA, metanephrin and normetanephrin, was
eDepartment of Endocrinology, Landspitali University Hospital, Reykjavik,
During the hospital stay, the patient needed high doses of
Corresponding Author: Helga A. Sigurjonsdottir, Department of Endocrinol-
potassium supplementation as well as anti-hypertensive and
ogy and Metabolism, Landspitali University Hospital 108, Reykjavik, Iceland.
Email:
[email protected]
insulin treatment. Over the course of several days the patient's
state worsened. She passed away only 26 days after her first
admittance to LSH and 33 days after she was first admitted
Articles The authors Journal compilation J Endocrinol Metab and Elmer Press Inc™ www.jofem.org
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited
Ectopic Cushing Syndrome
J Endocrinol Metab. 2014;4(5-6):153-154
ing the hospital period she needed large doses of potassium
supplements by infusion. The autopsy results support the clini-
cal and radiologic findings. The colon cancer was of a very
unusual morphologic type showing both conventional colonic
adenocarcinoma, as well as but predominantly a small cell car-
cinoma histology. The explosive elevation of ACTH secretion
from 769 to 4,658 ng/L in 17 days, and the resistant hyperten-
sion, hyperglycemia and hypokalemia give the impression that
the tumor was growing at an extremely fast rate. Unfortunately
the first plasma ACTH levels did not arrive until 1 week after
they were taken. Retrospectively, there were some alarming
clinical signs during the hospital admission, i.e., the extreme
hypertension and hypokalemia. In spite of that, the extreme
progress of the disease and the profound metastatic growth of
the tumor indicate that earlier diagnoses during the hospital
stay would not have changed the outcome. The symptoms of
hypercortisolism were the clinical signs of this malignant co-
Figure 1. Biopsy from primary tumor in colon. On the left is a classic
lon cancer, and possibly the myocardial infarct and heart fail-
adenocarcinoma of colon (A) and on the right a small cell carcinoma
ure were secondary to that. Apart from a similar case [1] in
2010 there has been no report on this kind of tumor in the Eng-
to the primary hospital. Autopsy revealed a primary tumor in
lish literature in recent years. A thorough literature search for
the sigmoid colon. The tumor proved to be a combined ad-
similar cases was performed and revealed only 10 previously
enocarcinoma and small cell carcinoma. The adenocarcinoma
reported cases of CS caused by ectopic ACTH producing colon
component was a conventional colonic type adenocarcinoma.
cancer. Another astonishing factor about this case is that the
The small cell (neuroendocrine carcinoma) component had the
primary colon cancer had dual morphology, both adenocarci-
same appearance as the well known small cell anaplastic car-
noma and small cell carcinoma. Neuroendocrine tumors of the
cinoma of the lung. Immunohistochemical stain of the primary
colon are extremely rare, estimated less than 1% of colorectal
tumor showed the adenocarcinoma to be positive for CK20.
cancers with bad overall outcome. They behave aggressively
The small cell carcinoma was positive for neuron specific eno-
as most patients have metastases at the time of diagnosis [4, 5].
lase (NSE), chromogranin, synaptophysin and ACTH (in less
than 5% of the SCC tumor cells) (Fig. 1). Widespread metasta-
ses were present in the body, but solely from the small cell car-
cinoma component of the tumor. Lymph node metastases were
1. Sehgal R, Mchayleh W, Reider J, et al. Adenocarcinoma
detected in the pericolonic, peripancreatic, para-aortical and
of Colon Presenting As Cushing's syndrome. Journal of
mediastinal lymph nodes. Massive metastases were also pre-
Clinical Oncology. 2010;28:126-127.
sent in the liver and lungs. No abnormal growth was detected
2. Miura K, Demura H, Sato E, Sasano N, Shimizu N. A
in the bone marrow and the megakaryocytes were normal. An
case of ACTH-secreting cancer of the colon. J Clin Endo-
immunohistochemical stain for ACTH was performed on one
crinol Metab. 1970;31(5):591-595.
of the metastases, and this illustrated positive tumor cells as
3. Anthoney DA, Dunlop DJ, Connell JM, Kaye SB. Colon-
well as in the primary tumor.
ic adenocarcinoma associated ectopic ACTH secretion: a
case history. Eur J Cancer. 1995;31A(12):2109-2112.
4. Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi
W, Thaler H, et al. Neuroendocrine carcinomas of the co-
lon and rectum. Dis Colon Rectum. 2004;47(2):163-169.
We present a very unusual type of colon cancer presenting with
5. Jung SH, Kim HC, Yu CS, Chang HM, Ryu MH, Lee JL,
CS. The explosive progression of the disease is alarming. The
Kim JS, et al. [Clinicopathologic characteristics of colo-
patient passed away only 33 days following admission to a
rectal neuroendocrine tumor]. Korean J Gastroenterol.
hospital. Two months earlier she was normokalemic, but dur-
Articles The authors Journal compilation J Endocrinol Metab and Elmer Press Inc™ www.jofem.org
Source: https://www.krabb.is/media/baeklingar/Ectopiccusthingrannsokn.pdf
WOMEN'S HEALTH QUESTIONNAIRE This questionnaire is designed for women who are experiencing menstrual, menopausal and/or gynaecological health concerns. Your answers will assist your practitioner in gaining information about your presentation and assist in the creation of your treatment plan. HOW TO USE THE QUESTIONNAIRE When answering, please consider your symptoms from the last 6 months.
The NEW ENGL A ND JOUR NA L of MEDICI NE Helping Smokers Quit — Opportunities Created by the Affordable Care ActTim McAfee, M.D., M.P.H., Stephen Babb, M.P.H., Simon McNabb, B.A., and Michael C. Fiore, M.D., M.P.H., M.B.A. In its review of tobacco-dependence treatments, thereby increase rates of cessa- the 2008 clinical practice guideline of the U.S.